Literature DB >> 12790770

Quaternary benzo[c]phenanthridine alkaloids as inhibitors of dipeptidyl peptidase IV-like activity baring enzymes in human blood plasma and glioma cell lines.

A Sedo1, R Malík, J Vicar, V Simánek, J Ulrichová.   

Abstract

Quaternary benzo[c]phenanthridine alkaloids (QBA), fagaronine (FA), sanguinarine (SA), chelerythrine (CHE) and the QBA extract from Macleya cordata (EX) exerted differential inhibitory effect on the hydrolytic activity of particular dipeptidyl peptidase (DPP)-like enzyme isolated from human blood plasma and from human and rat glioma cell lines. The low-MW form of DPP-IV-like enzyme activity, corresponding most probably to DPP-8, observed only in glioma cells but not in human plasma, was inhibited preferentially by SA, CHE and EX, and only slightly by FA. The alkaloid inhibitory effect was concentration-dependent in the range 25-150 mM and directly pH-related. In addition, a subtle but consistent inhibition of the intermediate-MW form of DPP-IV-like enzyme activity, ascribed to DPP-IV/CD26, observed only in human plasma and of the attractin (high-MW form of DPP-IV-like enzyme activity, expressed in U87 glioma cells) by the studied alkaloids was observed. We conclude that some of the QBA biological effects could be determined by tissue and cell type specific dipeptidyl peptidase IV-like molecules expression pattern.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790770

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  2 in total

1.  Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-α in transformed astrocytic cells.

Authors:  Eva Balaziova; Petr Busek; Jarmila Stremenova; Lucie Sromova; Evzen Krepela; Libuse Lizcova; Aleksi Sedo
Journal:  Mol Cell Biochem       Date:  2011-04-28       Impact factor: 3.396

Review 2.  Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.

Authors:  Pravindra Kumar; Ashok Kumar Sah; Greesham Tripathi; Avantika Tripathi; Anjali Kashyap; Rashmi Rao; Prabhu C Mishra; Koustav Mallick; Amjad Husain; Manoj Kumar Kashyap
Journal:  Mol Cell Biochem       Date:  2020-10-07       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.